Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 28 Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 17 Biliary Tract Neoplasms 13 Small Cell Lung Carcinoma 12 Cholangiocarcinoma 12 Triple Negative Breast Neoplasms 8 Breast Neoplasms 8 Neoplasms 6 Neoplasm Metastasis 5 Liver Neoplasms 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Carcinoma 4 Pancreatic Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Gallbladder Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma Of Esophagus 3 Pathologic Complete Response 2 Ovarian Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Bile Duct Neoplasms 2 Advanced Biliary Tract Cancer 2 Adenocarcinoma of Lung 2 Adenocarcinoma 2 Vaccinia 1 SCLC, Limited Stage 1 Resectable Intrahepatic Cholangiocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 23 Radiosurgery 21 Temozolomide 14 Bevacizumab 12 pembrolizumab 10 Specimen Handling 9 Nivolumab 8 Radiotherapy 7 Ipilimumab 7 Magnetic Resonance Imaging 6 Cyclophosphamide 5 Capecitabine 5 Blood Specimen Collection 5 encorafenib 4 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Memantine 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 binimetinib 3 abemaciclib 3 Watchful Waiting 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × durvalumab × Clear all

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡